<biology_intro>
  <fulltextID>text033</fulltextID>
  <title>Structure and dynamics of the RF-amide QRFP receptor GPR103</title>
  <authors>Aika Iwama, Hiroaki Akasaka, Fumiya K. Sano, Hidetaka S. Oshima, Wataru Shihoya, Osamu Nureki</authors>
  <doi>https://doi.org/10.1101/2023.12.06.570340</doi>
  <source>bioarxiv</source>
  <category>Biochemistry</category>
  <fulltext>
    <paragraph>
      <sentence>
        <sentenceID>t033s001</sentenceID>
        <step>1a</step>
        <text>Neuropeptides, a diverse array of signaling molecules, orchestrate a multitude of physiological processes in organisms.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s002</sentenceID>
        <step>1a</step>
        <text>Among them, neuropeptides possessing the Arg-Phe-NH2 (RFamide) motif at their C-termini are designated as RFamide peptides and have attracted considerable attentions because of their pivotal roles in various biological functions [1–3].</text>
      </sentence>
      <sentence>
        <sentenceID>t033s003</sentenceID>
        <step>1b</step>
        <text>The RF-amide family encompasses five distinct peptides: Neuropeptide FF (NPFF), Prolactin-releasing peptide (PrRP), Kisspeptin (Kiss1), gonadotropin-inhibitory hormone (GnIH), and pyroglutamylated RFamide peptide (QRFP).</text>
      </sentence>
      <sentence>
        <sentenceID>t033s004</sentenceID>
        <step>1b</step>
        <text>Each peptide interacts with specific class A G-protein-coupled receptors (GPCRs), initiating a cascade of intracellular events to modulate physiological responses.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s005</sentenceID>
        <step>1b</step>
        <text>Similarly, the RY-amide peptides, characterized by the signature RY motif at their C-termini, present a similar mode of action, interacting with their respective receptors to regulate physiological processes [4].</text>
      </sentence>
      <sentence>
        <sentenceID>t033s006</sentenceID>
        <step>1b</step>
        <text>This categorization based on the C-terminal residues highlights the specificity and diversity within these peptide families.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s007</sentenceID>
        <step>1b</step>
        <text>The intricate interplay between these peptides and their receptors represents a complex network critical for maintaining homeostasis and responding to environmental changes.</text>
      </sentence>
    </paragraph>
    <paragraph>
      <sentence>
        <sentenceID>t033s008</sentenceID>
        <step>1b</step>
        <text>QRFP is a 43-amino acid RFamide peptide with a pyroglutamylated N-terminus (namely 43Rfa).</text>
      </sentence>
      <sentence>
        <sentenceID>t033s009</sentenceID>
        <step>1b</step>
        <text>QRFP was originally identified by a bioinformatics approach and reverse pharmacology[5], and demonstrates specific activity for GPR103 with orexigenic activity[5–7], a Gq-coupled receptor expressed in the brain and adrenal gland.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s010</sentenceID>
        <step>1b</step>
        <text>GPR103 is predominantly localized in the central nervous system, including regions such as the hypothalamus, which plays a crucial role in the regulation of energy metabolism and appetite control.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s011</sentenceID>
        <step>1c</step>
        <text>QRFP and GPR103 are implicated in a variety of physiological functions ranging from the modulation of feeding behavior to the regulation of energy homeostasis [8], cardiovascular function and bone formation [9].</text>
      </sentence>
      <sentence>
        <sentenceID>t033s012</sentenceID>
        <step>1c</step>
        <text>This QRFP-GPR103 pair is remarkably conserved across various vertebrate species[10], highlighting its fundamental significance in biological systems.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s013</sentenceID>
        <step>1a</step>
        <text>GPR103 is not only pivotal in maintaining physiological balance but also presents therapeutic targets for disorders related to metabolism and appetite dysregulation.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s014</sentenceID>
        <step>1a</step>
        <text>For example, QRFP administration reportedly increased food intake and fat mass while reducing glucose-induced insulin release, and may also cause osteopenia and facilitate nociception [11].</text>
      </sentence>
      <sentence>
        <sentenceID>t033s015</sentenceID>
        <step>1a</step>
        <text>Thus, the GPR103 antagonist demonstrated an anorexigenic effect in mice, and has been focused as a treatment for obesity.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s016</sentenceID>
        <step>1b</step>
        <text>Additionally, the GPR103 antagonist would be useful to trigger dormant state for survival treatment in emergency medical care.</text>
      </sentence>
    </paragraph>
    <paragraph>
      <sentence>
        <sentenceID>t033s017</sentenceID>
        <step>1c</step>
        <text>Recent advancements in cryo-electron microscopy (cryo-EM) have unveiled numerous GPCR-G-protein complex structures, including those associated with C-terminally amidated peptides such as cholecystokinin, orexin, and RY-amide neuropeptide Y[12–14].</text>
      </sentence>
      <sentence>
        <sentenceID>t033s018</sentenceID>
        <step>1c</step>
        <text>These analyses have shed light on the intricacies of ligand-receptor interactions and their activation mechanisms.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s019</sentenceID>
        <step>2b</step>
        <text>Nevertheless, a notable gap remains in our understanding of RF-amide receptors, specifically GPR103.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s020</sentenceID>
        <step>2b</step>
        <text>The structures of these receptors have not been elucidated, leaving the mechanisms distinguishing RF- and RY-amides enigmatic.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s021</sentenceID>
        <step>2b</step>
        <text>This also includes an understanding of the selective activation of GPR103 by QRFP and the fundamental principles dictating ligand specificity among related receptors.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s022</sentenceID>
        <step>2b</step>
        <text>These gaps in structural data significantly hinder the strategic development of therapeutic agents targeting GPR103.</text>
      </sentence>
      <sentence>
        <sentenceID>t033s023</sentenceID>
        <step>3a</step>
        <text>Here, we report a cryo-EM structure of the QRFP-bound GPR103•Gq complex, offering deep insights into its ligand recognition and selectivity, and dynamics.</text>
      </sentence>
    </paragraph>
  </fulltext>
</biology_intro>